NCT00361829 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Kuiumdzhieva A, Denchev D
[ATP yield from yeasts of the genera Candida and Torulopsis cultured in a chemostat on a methanol medium]. Acta Microbiol Bulg. 1984;15:50-5. No abstract available. Bulgarian.
Rowe A
Characteristics of hospital care. Nurs Times. 1969 Oct 23;65(43):1376-7. No abstract available.
Smith WL, Egle JL Jr, Adams MD
Adrenergic receptors in the nucleus tractus solitarii of the rat. Eur J Pharmacol. 1982 Jun 16;81(1):11-9. doi: 10.1016/0014-2999(82)90596-9.

Specificity of Mother-Infant Interaction: The Influence of Maternal Age, Employment Status, and Parenthood Status

Clinical trial NCT00361829 - References